Disease-specific composite measures for psoriatic arthritis are highly responsive to a Janus kinase inhibitor treatment that targets multiple domains of disease

Helliwell, P, Coates, LC, FitzGerald, O et al. (8 more authors) (2018) Disease-specific composite measures for psoriatic arthritis are highly responsive to a Janus kinase inhibitor treatment that targets multiple domains of disease. Arthritis Research and Therapy, 20. 242. ISSN 1478-6354

Abstract

Metadata

Authors/Creators:
  • Helliwell, P
  • Coates, LC
  • FitzGerald, O
  • Nash, P
  • Soriano, ER
  • Husni, ME
  • Hsu, M-A
  • Kanik, KS
  • Hendrikx, T
  • Wu, J
  • Kudlacz, E
Copyright, Publisher and Additional Information: © 2018, The Author(s). This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Keywords: Psoriatic arthritis; Assessment; PASDAS; DAPSA; CPDAI; DAS28-3(CRP)
Dates:
  • Published: 29 October 2018
  • Accepted: 2 October 2018
  • Published (online): 29 October 2018
Institution: The University of Leeds
Depositing User: Symplectic Publications
Date Deposited: 15 Nov 2018 10:57
Last Modified: 15 Nov 2018 10:57
Status: Published
Publisher: BioMed Central
Identification Number: https://doi.org/10.1186/s13075-018-1739-0

Share / Export

Statistics